ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Sun Yat-sen University · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
chemotherapy
nasopharyngeal cancinoma (npc), recurrent nasopharynx carcinoma, metastatic nasopharyngeal carcinoma, egfr antibody, pd-1 antibody, chemotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804858
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.